Perrigo (PRGO) Other Non Operating Income (2013 - 2026)
Perrigo (PRGO) posted quarterly Other Non Operating Income of $6.0 million for Q1 2026, up 1400.0% year-over-year from $400000.0 in Q1 2025, and up 561.54% quarter-over-quarter from -$1.3 million in Q4 2025.
Perrigo (PRGO) Other Non Operating Income (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Other Non Operating Income for 14 consecutive years, with $6.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income rose 1400.0% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $2.1 million (up 121.88% YoY), while the FY2025 annual figure was -$13.2 million, down 97.01% from the prior year.
- Other Non Operating Income rose to $6.0 million in Q1 2026 per PRGO's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $9.7 million in Q3 2023 and bottomed at -$9.3 million in Q3 2022.
- Historically, Other Non Operating Income has averaged -$913333.3 across 5 years, with a median of -$1.3 million in 2025.
- Annual changes were most pronounced in 2023 — Other Non Operating Income slumped 145.45% — and 2026, when it jumped 1400.0%.
- Perrigo's Other Non Operating Income stood at -$4.4 million in 2022, then sank by 45.45% to -$6.4 million in 2023, then soared by 76.56% to -$1.5 million in 2024, then rose by 13.33% to -$1.3 million in 2025, then soared by 561.54% to $6.0 million in 2026.
- Business Quant data shows PRGO's Other Non Operating Income at $6.0 million in Q1 2026, -$1.3 million in Q4 2025, and -$2.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.77 Bn | 2.15 Bn |
| 3 | Zoetis | 31.87 Bn | 30.20 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.60 Bn | 683.80 Mn |
| 6 | Viatris | 18.81 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.69 Bn | 15.30 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.13 Bn | 11.60 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.17 Bn | 10.01 Bn | - |
| 10 | Perrigo | 1.90 Bn | 1.50 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 120.50 Mn |
| Mar 28, 2026 | 6.00 Mn |
| Dec 31, 2025 | -1.30 Mn |
| Jun 28, 2025 | -2.60 Mn |
| Mar 29, 2025 | 400,000.00 |
| Dec 31, 2024 | -1.50 Mn |
| Sep 28, 2024 | -5.10 Mn |
| Jun 29, 2024 | -3.40 Mn |
| Mar 30, 2024 | -400,000.00 |
| Dec 31, 2023 | -6.40 Mn |
| Jul 1, 2023 | 9.70 Mn |
| Apr 1, 2023 | -500,000.00 |
| Dec 31, 2022 | -4.40 Mn |
| Oct 1, 2022 | 4.00 Mn |
| Jul 2, 2022 | -9.30 Mn |
| Apr 2, 2022 | 1.10 Mn |
| Dec 31, 2021 | -18.50 Mn |
| Apr 3, 2021 | -2.40 Mn |
| Dec 31, 2020 | 1.60 Mn |
| Sep 26, 2020 | -20.00 Mn |